Kayon Partners

TerraLIX is a manufacturer specializing in hydrogen fuel cells and related products. The company focuses on developing fuel cell systems that can operate effectively in extreme environments, ensuring reliable energy sources even under challenging conditions. By providing advanced cell packs, TerraLIX aims to meet the growing demand for sustainable energy solutions in various applications.

Mom-sitter is a childcare platform based in Seoul, Korea, designed to connect parents with caregivers for children aged 0 to 13 years. The platform facilitates the matching process by providing detailed information about caregivers, including their specialties and legal backgrounds, to ensure that parents can make informed decisions. By assessing the needs of families seeking childcare services, Mom-sitter aims to match them with qualified babysitting professionals, thereby enhancing trust and safety in the babysitting experience.

InkHunter, Inc. is a company that develops a mobile application utilizing augmented reality to assist tattoo artists and enthusiasts in visualizing tattoo designs. Founded in 2014 and headquartered in New York, the application allows users to project tattoo designs onto any part of their body in real-time, helping them to assess size and placement before making a permanent decision. Users can select designs from a gallery or upload their own creations, and they have the ability to resize and reposition the tattoos from various angles. The app also enables users to edit photos and share their tattoo designs with friends, enhancing the overall experience of selecting a tattoo.

Intarcia Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for chronic conditions that require long-term management. The company is known for its innovative Medici Drug Delivery System, which facilitates subcutaneous delivery of therapies for diseases such as type 2 diabetes, obesity, and autoimmune disorders. Its lead product, ITCA 650, is currently in phase 3 clinical trials designed to provide sustained treatment for diabetes through a steady-state dosing system. Additionally, Intarcia's DUROS platform stabilizes and delivers therapeutic proteins and peptides, including devices aimed at treating conditions such as Hepatitis C. Founded in 1997 and originally named BioMedicines, the company rebranded to Intarcia Therapeutics in 2004. It is headquartered in Boston, Massachusetts, with a manufacturing facility in Hayward, California, and a research and development center in Durham, North Carolina.

Harrington Re Ltd. is a Bermuda based, multi-line reinsurance company jointly sponsored by AXIS Capital Holdings Limited and Blackstone Group L.P. and is registered as a Class 4 Insurer with the Bermuda Monetary Authority. The Company has total capital of approximately $600 million (including $50 million of senior debt) and has been awarded an A- (“Excellent”) financial strength rating by A.M. Best.

Symbiont.io, Inc. is a financial technology company that specializes in developing a smart contracts platform tailored for institutional applications of blockchain technology. Founded in 2013 and headquartered in New York City, with an additional office in Amsterdam, the company provides a comprehensive infrastructure for capital markets. This includes a unified ledger for sharing business logic and market data, as well as the Symbiont Assembly platform, which facilitates the issuance, tracking, and management of financial instruments such as loans, securities, and commodities. By enabling complex financial instruments to exist within a decentralized blockchain network, Symbiont aims to enhance transparency, reduce risk, and lower costs for financial institutions and government entities. The company has established partnerships with industry leaders, including Vanguard and the State of Delaware, to drive innovation and improve operational efficiency in the capital markets sector.